263 related articles for article (PubMed ID: 28209155)
1. Intranasal oxytocin reduces provoked symptoms in female patients with posttraumatic stress disorder despite exerting sympathomimetic and positive chronotropic effects in a randomized controlled trial.
Sack M; Spieler D; Wizelman L; Epple G; Stich J; Zaba M; Schmidt U
BMC Med; 2017 Feb; 15(1):40. PubMed ID: 28209155
[TBL] [Abstract][Full Text] [Related]
2. Intranasal Oxytocin to Prevent Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial in Emergency Department Patients.
van Zuiden M; Frijling JL; Nawijn L; Koch SBJ; Goslings JC; Luitse JS; Biesheuvel TH; Honig A; Veltman DJ; Olff M
Biol Psychiatry; 2017 Jun; 81(12):1030-1040. PubMed ID: 28087128
[TBL] [Abstract][Full Text] [Related]
3. Intranasal Oxytocin Affects Amygdala Functional Connectivity after Trauma Script-Driven Imagery in Distressed Recently Trauma-Exposed Individuals.
Frijling JL; van Zuiden M; Koch SB; Nawijn L; Veltman DJ; Olff M
Neuropsychopharmacology; 2016 Apr; 41(5):1286-96. PubMed ID: 26346640
[TBL] [Abstract][Full Text] [Related]
4. A Preliminary Examination of Endogenous Peripheral Oxytocin in a Pilot Randomized Clinical Trial of Oxytocin-Enhanced Psychotherapy for Posttraumatic Stress Disorder.
Sippel LM; King CE; Wahlquist AE; Flanagan JC
J Clin Psychopharmacol; 2020; 40(4):401-404. PubMed ID: 32639293
[TBL] [Abstract][Full Text] [Related]
5. Craving Moderates the Effects of Intranasal Oxytocin on Anger in Response to Social Stress Among Veterans With Co-Occurring Posttraumatic Stress Disorder and Alcohol Use Disorder.
Melkonian AJ; Flanagan JC; Calhoun CD; Hogan JN; Back SE
J Clin Psychopharmacol; 2021 Jul-Aug 01; 41(4):465-469. PubMed ID: 34121063
[TBL] [Abstract][Full Text] [Related]
6. Augmenting Prolonged Exposure therapy for PTSD with intranasal oxytocin: A randomized, placebo-controlled pilot trial.
Flanagan JC; Sippel LM; Wahlquist A; Moran-Santa Maria MM; Back SE
J Psychiatr Res; 2018 Mar; 98():64-69. PubMed ID: 29294429
[TBL] [Abstract][Full Text] [Related]
7. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
Auxéméry Y
Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxytocin on stress reactivity and craving in veterans with co-occurring PTSD and alcohol use disorder.
Flanagan JC; Allan NP; Calhoun CD; Badour CL; Moran-Santa Maria M; Brady KT; Back SE
Exp Clin Psychopharmacol; 2019 Feb; 27(1):45-54. PubMed ID: 30382728
[TBL] [Abstract][Full Text] [Related]
9. Effects of intranasal oxytocin on distraction as emotion regulation strategy in patients with post-traumatic stress disorder.
Koch SBJ; van Zuiden M; Nawijn L; Frijling JL; Veltman DJ; Olff M
Eur Neuropsychopharmacol; 2019 Dec; 29(2):266-277. PubMed ID: 30554861
[TBL] [Abstract][Full Text] [Related]
10. Automatic Imitation in Comorbid PTSD & Alcohol Use Disorder and Controls: an RCT of Intranasal Oxytocin.
Morrison TE; De Coster L; Stauffer CS; Wen J; Ahmadi E; Delucchi K; O'Donovan A; Woolley J
Psychoneuroendocrinology; 2020 Oct; 120():104787. PubMed ID: 32745891
[TBL] [Abstract][Full Text] [Related]
11. Intranasal oxytocin increases neural responses to social reward in post-traumatic stress disorder.
Nawijn L; van Zuiden M; Koch SB; Frijling JL; Veltman DJ; Olff M
Soc Cogn Affect Neurosci; 2017 Feb; 12(2):212-223. PubMed ID: 27614769
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of oxytocin administration early after psychotrauma in preventing the development of PTSD: study protocol of a randomized controlled trial.
Frijling JL; van Zuiden M; Koch SB; Nawijn L; Goslings JC; Luitse JS; Biesheuvel TH; Honig A; Bakker FC; Denys D; Veltman DJ; Olff M
BMC Psychiatry; 2014 Mar; 14():92. PubMed ID: 24679046
[TBL] [Abstract][Full Text] [Related]
13. Pilot test of intranasal oxytocin as an enhancer of brief couples therapy for posttraumatic stress disorder.
Sippel LM; Khalifian CE; Knopp KC; Webster K; Maglione J; Holcomb J; Flanagan JC; Monson CM; Holtzheimer PE; Morland LA
J Psychiatr Res; 2023 May; 161():165-169. PubMed ID: 36931134
[TBL] [Abstract][Full Text] [Related]
14. COPE and oxytocin for the treatment of co-occurring PTSD and alcohol use disorder: Design and methodology of a randomized controlled trial in U.S. military veterans.
Back SE; Flanagan JC; Killeen T; Saraiya TC; Brown DG; Jarnecke AM; Rothbaum AO; Joseph J; Ana ES; de Arellano A; Shoemaker HL; Dixon RA; Nietert PJ; Brady KT
Contemp Clin Trials; 2023 Mar; 126():107084. PubMed ID: 36646315
[TBL] [Abstract][Full Text] [Related]
15. Design of a randomized clinical trial of brief couple therapy for PTSD augmented with intranasal oxytocin.
Sippel LM; Wachsman TR; Kelley ME; Knopp KC; Khalifian CE; Maglione JE; Glynn SM; Macdonald A; Monson CM; Flanagan JC; Holtzheimer PE; Morland LA
Contemp Clin Trials; 2024 Jun; 141():107534. PubMed ID: 38614447
[TBL] [Abstract][Full Text] [Related]
16. Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial.
Flanagan JC; Mitchell JM; Baker NL; Woolley J; Wangelin B; Back SE; McQuaid JR; Neylan TC; Wolfe WR; Brady KT
Contemp Clin Trials; 2020 Aug; 95():106074. PubMed ID: 32561468
[TBL] [Abstract][Full Text] [Related]
17. Oxytocin receptor is a potential biomarker of the hyporesponsive HPA axis subtype of PTSD and might be modulated by HPA axis reactivity traits in humans and mice.
Hofmann J; Huber C; Novak B; Schreckenbach M; Schubert CF; Touma C; Rutten BP; Schmidt U
Psychoneuroendocrinology; 2021 Jul; 129():105242. PubMed ID: 33975150
[TBL] [Abstract][Full Text] [Related]
18. Intranasal Oxytocin Administration Dampens Amygdala Reactivity towards Emotional Faces in Male and Female PTSD Patients.
Koch SB; van Zuiden M; Nawijn L; Frijling JL; Veltman DJ; Olff M
Neuropsychopharmacology; 2016 May; 41(6):1495-504. PubMed ID: 26404844
[TBL] [Abstract][Full Text] [Related]
19. Effects of oxytocin administration on fear-potentiated acoustic startle in co-occurring PTSD and alcohol use disorder: A randomized clinical trial.
Stauffer CS; Morrison TE; Meinzer NK; Leung D; Buffington J; Sheh EG; Neylan TC; O'Donovan A; Woolley JD
Psychiatry Res; 2022 Feb; 308():114340. PubMed ID: 34983010
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy for posttraumatic stress disorder.
Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S
Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
